{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:54:19Z","timestamp":1793109259440,"version":"4.5.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The incidence of non-Hodgkin\u2019s lymphoma (NHL) has increased steadily over the past few decades. Elucidating its global burden will facilitate more effective disease management and improve patient outcomes. We explored the disease burden, risk factors, and trends in incidence and mortality in NHL globally.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The up-to-date data on age-standardized incidence and mortality rates of NHL were retrieved from the GLOBOCAN 2020, CI5 volumes I-XI, WHO mortality database, and Global Burden of Disease (GBD) 2019, focusing on geographic disparities worldwide. We reported incidence and mortality by sex and age, along with corresponding age-standardized rates (ASRs), the average annual percentage change (AAPC), and future burden estimates to 2040.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2020, there were an estimated 545,000 new cases and 260,000 deaths of NHL globally. In addition, NHL resulted in 8,650,352 age-standardized DALYs in 2019 worldwide. The age-specific incidence rates varied drastically across world areas, at least 10-fold in both sexes, with the most pronounced increase trend found in Australia and New Zealand. By contrast, North African countries faced a more significant mortality burden (ASR, 3.7 per 100,000) than highly developed countries. In the past decades, the pace of increase in incidence and mortality accelerated, with the highest AAPC of 4.9 (95%CI: 3.6-6.2) and 6.8 (95%CI: 4.3-9.2) in the elderly population, respectively. Considering risk factors, obesity was positively correlated with age-standardized incidence rates (P&amp;lt; 0.001). And North America was the high-risk region for DALYs due to the high body mass index in 2019. Regarding demographic change, NHL incident cases are projected to rise to approximately 778,000 by 2040.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this pooled analysis, we provided evidence for the growing incidence trends in NHL, particularly among women, older adults, obese populations, and HIV-infected people. And the marked increase in the older population is still a public health issue that requires more attention. Future efforts should be directed at cultivating health awareness and formulating effective and locally tailored cancer prevention strategies, especially in most developing countries.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2023.1059914","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T10:34:19Z","timestamp":1685702059000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":95,"title":["The epidemiological patterns of non-Hodgkin lymphoma: global estimates of disease burden, risk factors, and temporal trends"],"prefix":"10.3389","volume":"13","author":[{"given":"Yurou","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosheng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/annonc\/mdr167","article-title":"Epidemiology of adult non-Hodgkin lymphoma","volume":"22","author":"Boffetta","year":"2011","journal-title":"Ann Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA-Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgu013","article-title":"Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph non-Hodgkin lymphoma subtypes project","author":"Morton","year":"2014","journal-title":"J Natl Cancer Instit Monogr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29490","article-title":"Are lifestyle behavioral factors associated with health-related quality of life in long-term survivors of non-Hodgkin lymphoma","volume":"121","author":"Spector","year":"2015","journal-title":"Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7326\/m14-2768","article-title":"Cumulative incidence of cancer among persons with HIV in north America a cohort study","volume":"163","author":"Silverberg","year":"2015","journal-title":"Ann Intern Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-04-537498","article-title":"Familial predisposition and genetic risk factors for lymphoma","volume":"126","author":"Cerhan","year":"2015","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3018(18)30360-6","article-title":"Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study","volume":"6","author":"Hernandez-Ramirez","year":"2019","journal-title":"Lancet HIV"},{"key":"B9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/s1470-2045(14)71123-4","article-title":"Global burden of cancer attributable to high body-mass index in 2012: a population-based study","volume":"16","author":"Arnold","year":"2015","journal-title":"Lancet Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18150","article-title":"Body size and risk of non-Hodgkin lymphoma by subtype: a pooled analysis from six prospective cohorts in the united states","volume":"197","author":"Teras","year":"2022","journal-title":"Br J Haematol"},{"key":"B11","unstructured":"Non-hodgkin\u2019s lymphoma statistics2012"},{"key":"B12","unstructured":"Global cancer observatory: cancer today\n            Ferlay JEM\n            LamF\n          2020"},{"key":"B13","unstructured":"Global data on HIV epidemiology and response2020"},{"key":"B14","unstructured":"Global health observatory data repository2016"},{"key":"B15","unstructured":"FerlayJ\n          LyonInternational Agency for Research on CancerCancer incidence in five continents2017"},{"key":"B16","unstructured":"WHO mortality database2020"},{"key":"B17","unstructured":"Global burden of disease2019"},{"key":"B18","article-title":"Geographical observation on cancer mortality by selected sites on the basis of standardised death rate","volume":"48","author":"Segi","year":"1957","journal-title":"Gan"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.12.001","article-title":"The trends in incidence of primary liver cancer caused by specific etiologies: results from the global burden of disease study 2016 and implications for liver cancer prevention","volume":"70","author":"Liu","year":"2019","journal-title":"J Hepatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0258(20000215)19:3<335::Aid-sim336>3.0.Co;2-z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3733","article-title":"Estimating average annual per cent change in trend analysis","volume":"28","author":"Clegg","year":"2009","journal-title":"Stat Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2022.2039957","article-title":"Global, regional and national burden of non-Hodgkin lymphoma from 1990 to 2017: estimates from global burden of disease study in 2017","volume":"54","author":"Sun","year":"2022","journal-title":"Ann Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.2706","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study","volume":"4","author":"Fitzmaurice","year":"2018","journal-title":"JAMA Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2013.10.005","article-title":"Obesity is associated with increased relative risk of diffuse Large b-cell lymphoma: a meta-analysis of observational studies","volume":"14","author":"Castillo","year":"2014","journal-title":"Clin Lymp Myeloma Leuk"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12659","article-title":"Differences in incidence and trends of haematological malignancies in Japan and the united states British","volume":"164","author":"Chihara","year":"2014","journal-title":"J Haematol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/s0140-6736(16)32407-2","article-title":"Non-Hodgkin lymphoma","volume":"390","author":"Armitage","year":"2017","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-01791400","article-title":"Optimizing treatment of HIV-associated lymphoma","volume":"134","author":"Noy","year":"2019","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(03)00983-5","article-title":"Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS","volume":"4","author":"Dal Maso","year":"2003","journal-title":"Lancet Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgu003","article-title":"Medical history, lifestyle, family history, and occupational risk factors for sporadic burkitt lymphoma\/leukemia: the interlymph non-Hodgkin lymphoma subtypes project","volume":"2014","author":"Mbulaiteye","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051447","article-title":"HIV-Associated lymphomas: progress and new challenges","volume":"11","author":"Pongas","year":"2022","journal-title":"J Clin Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.1998.7.1247","article-title":"The influence of sex hormones on obesity across the female life span","volume":"7","author":"Lovejoy","year":"1998","journal-title":"J Womens Health"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1177\/2040620721996484","article-title":"Current treatment options for aggressive non-Hodgkin lymphoma in elderly and frail patients: practical considerations for the hematologist","volume":"12","author":"Schmittlutz","year":"2021","journal-title":"Ther Adv Hematol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04345-3","article-title":"Age-dependent increase of treatment-related mortality in older patients with aggressive b cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive b cell lymphoma-data from phase II and III trials of the DSHNHL (German high-grade non-hodgkin's lymphoma study group)","volume":"100","author":"Zettl","year":"2021","journal-title":"Ann Hematol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-01018-6","article-title":"How we treat mature b-cell neoplasms (indolent b-cell lymphomas)","volume":"14","author":"Lumish","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004286","article-title":"Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose r-CHOP","volume":"5","author":"Eyre","year":"2021","journal-title":"Blood Adv"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06502-2","article-title":"Critical illness in patients with hematologic malignancy: a population-based cohort study","volume":"47","author":"Ferreyro","year":"2021","journal-title":"Intensive Care Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1059914\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T10:34:23Z","timestamp":1685702063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1059914\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":37,"alternative-id":["10.3389\/fonc.2023.1059914"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1059914","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,2]]},"article-number":"1059914"}}